Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in

Ying-Lu Cui1, Qing-Chuan Zheng, Ji-Long Zhang

  • 1State Key Laboratory of Theoretical and Computational Chemistry, Institute of Theoretical Chemistry, Jilin University , Changchun, Jilin 130023, P. R. China.

Insights

Computer simulations reveal how mutations in Cytochrome P450 (CYP) 17A1 affect steroid hormone synthesis. Understanding these changes in enzyme structure and tunnel dynamics helps explain activity deficiencies and guides future research.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Chemistry

Background:

  • Cytochrome P450 (CYP) 17A1 is crucial for human steroid hormone synthesis.
  • CYP 17A1 is a therapeutic target for hormone-dependent cancers like breast and prostate cancer.
  • Experimental data exists on CYP 17A1 mutations, but atomic-level understanding of activity loss is lacking.

Purpose of the Study:

  • To investigate the structural and dynamic effects of single point mutations in CYP 17A1.
  • To rationalize the molecular origins of enzymatic activity deficiencies at atomic resolution.
  • To bridge the gap between theoretical models and experimental observations of CYP 17A1 function.

Main Methods:

  • Molecular Dynamics (MD) simulations.
  • Potential of Mean Force (PMF) calculations.
  • Molecular Mechanics with Generalized Born Surface Area (MM-GBSA) calculations.

Main Results:

  • An 'access mechanism' was defined, explaining how mutations alter structural flexibility and tunnel dynamics.
  • Mutations were linked to changes in conformational flexibility and tunnel opening.
  • Hydrophobic residue proximity or disruption of the hydrophobic core may underlie these conformational changes.

Conclusions:

  • The study provides atomic-level insights into CYP 17A1 structure-function relationships.
  • Findings enhance understanding of 17-hydroxylase deficiencies and polycystic ovary disease.
  • Knowledge of ligand binding and key residues can guide future computational and experimental studies on CYPs.

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
349
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Mutations01:39

Mutations

Overview
66.9K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Mismatch Repair01:36

Mismatch Repair

Overview
38.2K